Fig. 5 | Scientific Reports

Fig. 5

From: Metformin and chloroquine enhanced the efficacy of cytarabine in acute lymphoblastic leukemia cell lines: a drug repositioning approach

Fig. 5

Effects of different drug treatment groups on MDA levels after 48-h incubation on NALM-6. Values are reported as mean ± standard deviation. Cytarabine group (AraC), Metformin group (Met), chloroquine group (CQ), Metformin and Cytarabine group (Met +AraC) and chloroquine and Cytarabine group (CQ+AraC). Data are represented as mean ± SD (n = 3 independent experiments). **** P < 0.0001, ***P  < 0.001, **P  < 0.01, MDA: Malondialdehyde.

Back to article page